Editorial
Accepted on 16 Dec 2024
Editorial: Gene Therapy and Genome Editing for Metabolic Liver Disorders
Frontiers in Molecular Medicine
doi 10.3389/fmmed.2024.1543685
Volumes
74 Publications
Volume 4 - 2024
Original Research
Accepted on 10 Dec 2024
Immune-checkpoint-inhibitor therapy directed against PD-L1 is tolerated in the heart without manifestation of cardiac inflammation in a preclinical reversible melanoma mouse model
Frontiers in Molecular Medicine
doi 10.3389/fmmed.2024.1487526
Review
Accepted on 09 Dec 2024
Bibliometric and Visual Analysis of Global Colorectal Cancer Circular RNA Research 2015-2023
Frontiers in Molecular Medicine
doi 10.3389/fmmed.2024.1483286
Brief Research Report
Accepted on 28 Nov 2024
An Artificial Transcription Factor that Activates Potent Interferon-Îł Expression in Human Jurkat T Cells
Frontiers in Molecular Medicine
doi 10.3389/fmmed.2024.1492370
Opinion
Published on 27 Nov 2024
Human-specific gene ARHGAP11B—potentially an additional tool in the treatment of neurodegenerative diseases?
Frontiers in Molecular Medicine
doi 10.3389/fmmed.2024.1465647
- 252 views
Hypothesis and Theory
Published on 18 Sep 2024
DeltaRex-G, tumor targeted retrovector encoding a CCNG1 inhibitor, for CAR-T cell therapy induced cytokine release syndrome
Frontiers in Molecular Medicine
doi 10.3389/fmmed.2024.1461151
- 712 views
Review
Published on 06 Sep 2024
Role of epigenetic in cancer biology, in hematologic malignancies and in anticancer therapy
Frontiers in Molecular Medicine
doi 10.3389/fmmed.2024.1426454
- 1,378 views
Editorial
Published on 03 Jul 2024
Editorial: Mitochondrial dysfunction affects mechano-energetic coupling in heart failure
Frontiers in Molecular Medicine
doi 10.3389/fmmed.2024.1433102
- 777 views
Original Research
Published on 29 Apr 2024
Tafazzin deficiency causes substantial remodeling in the lipidome of a mouse model of Barth Syndrome cardiomyopathy
Frontiers in Molecular Medicine
doi 10.3389/fmmed.2024.1389456
- 2,052 views
Editorial
Published on 27 Feb 2024
Editorial: Celebrating the 200th mendel’s anniversary: gene-targeted diagnostics and therapies for cancer
Frontiers in Molecular Medicine
doi 10.3389/fmmed.2024.1366963
- 1,463 views
Review
Published on 01 Feb 2024
Current advances in experimental and computational approaches to enhance CAR T cell manufacturing protocols and improve clinical efficacy
Frontiers in Molecular Medicine
doi 10.3389/fmmed.2024.1310002
- 7,413 views
- 1 citation
Original Research
Published on 26 Jan 2024
Combined analysis of host IFN-Îł, IL-2 and IP-10 as potential LTBI biomarkers in ESAT-6/CFP-10 stimulated blood
Frontiers in Molecular Medicine
doi 10.3389/fmmed.2024.1345510
- 2,210 views
- 1 citation
Volume 3 - 2023
Original Research
Published on 08 Jan 2024
Loss of PPARα function promotes epigenetic dysregulation of lipid homeostasis driving ferroptosis and pyroptosis lipotoxicity in metabolic dysfunction associated Steatotic liver disease (MASLD)
Frontiers in Molecular Medicine
doi 10.3389/fmmed.2023.1283170
- 2,696 views
Editorial
Published on 04 Jan 2024
Editorial: The role of glial cells in neurodegeneration
Frontiers in Molecular Medicine
doi 10.3389/fmmed.2023.1337286
- 1,568 views
Mini Review
Published on 06 Dec 2023
Spatial adjustment of bioenergetics, a possible determinant of contractile adaptation and development of contractile failure
Frontiers in Molecular Medicine
doi 10.3389/fmmed.2023.1305960
- 1,320 views
Editorial
Published on 09 Oct 2023
Editorial: Myocardium regeneration and cardioprotection
Frontiers in Molecular Medicine
doi 10.3389/fmmed.2023.1293183
- 1,334 views